West Nile neuroinvasive disease: Could ESR/CRP ratio be a screening biomarker?

J Med Virol. 2020 Aug;92(8):925-926. doi: 10.1002/jmv.25979. Epub 2020 May 25.

Authors

Stylianos Daios¹, George Polychronopoulos², Dimitrios Pilalas², Ifigeneia Nakou¹, Thomas Tegos³, Ilias Kanellos², Ioannis Vagropoulos¹, Christos Savopoulos², Georgia Kaiafa²

Affiliations

¹ Internal Medicine Department, General Hospital of Serres, Serres, Greece.
² First Propedeutic Department of Internal Medicine, Medical School, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ First Neurology Department, Medical School, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

PMID: 32383775
DOI: 10.1002/jmv.25979

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antibodies, Viral / cerebrospinal fluid
Biomarkers
Blood Sedimentation*
C-Reactive Protein / analysis*
Female
Humans
Male
Middle Aged
West Nile Fever / diagnosis*
West Nile virus / immunology

Substances

Antibodies, Viral
Biomarkers
C-Reactive Protein